John Hancock Strategic Series has filed its latest NPORT-P report, which reveals a total asset value of approximately $19.77 million as of August 31, 2026. This filing is significant as it highlights the firm's ongoing commitment to transparency and compliance in the investment management sector.
The report indicates that John Hancock Strategic Series, which is part of the investment management industry, continues to navigate the complexities of the municipal bond market. The company, incorporated in Massachusetts, has focused on providing investors with access to various investment strategies.
Background
John Hancock Strategic Series is an investment entity that operates under the regulatory framework of the SEC. The firm has been active in filing various reports, with the most recent filings including multiple NPORT-P forms on October 29, 2026. The company is known for its strategic approach to managing investment portfolios.
What the Filing Says
The NPORT-P filing details that the total assets amount to $19,767,431.97, with total liabilities reported at $102,076.09. This brings the net assets to approximately $19,665,355.88. The filing reflects a focus on municipal bonds, which are critical for funding public projects and infrastructure.
Impact
This update may affect investors and stakeholders interested in the municipal bond market, as it provides insights into the financial health and strategy of John Hancock Strategic Series. The firm's focus on municipal bonds indicates its commitment to this asset class, which can be influenced by various economic factors.
What's Next
The filing does not say what happens next. However, stakeholders will likely be monitoring future reports to assess how the company adapts to market conditions and manages its portfolio.
Read Next
Jefferies CEO Handler Reports Stock Transactions in SEC Filing
Brophy Michael Burkes sells 3,084 shares of Natera stock
Glenbrook Capital Management Boosts Stake in SenesTech
OS Therapies grants stock options to Chief Medical Officer
Belite Bio CEO Lin Yu-Hsin Vests 5,000 Shares
Chen Wan-Shan Reports Share Transaction for Belite Bio






